NO930649D0 - Maalkomponent-maaling - Google Patents

Maalkomponent-maaling

Info

Publication number
NO930649D0
NO930649D0 NO930649A NO930649A NO930649D0 NO 930649 D0 NO930649 D0 NO 930649D0 NO 930649 A NO930649 A NO 930649A NO 930649 A NO930649 A NO 930649A NO 930649 D0 NO930649 D0 NO 930649D0
Authority
NO
Norway
Prior art keywords
attached
sample
targets
specific gravity
target components
Prior art date
Application number
NO930649A
Other languages
English (en)
Other versions
NO930649L (no
Inventor
Robert A Levine
Stephen C Wardlaw
Rodolfo Rodriguez
Judith Britz
Thomas J Mercolino
Original Assignee
Robert A Levine
Stephen C Wardlaw
Becton Dickinson Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Robert A Levine, Stephen C Wardlaw, Becton Dickinson Co filed Critical Robert A Levine
Publication of NO930649D0 publication Critical patent/NO930649D0/no
Publication of NO930649L publication Critical patent/NO930649L/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/537—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
    • G01N33/5375—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody by changing the physical or chemical properties of the medium or immunochemicals, e.g. temperature, density, pH, partitioning
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/537—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
    • G01N33/538—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody by sorbent column, particles or resin strip, i.e. sorbent materials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/829—Liposomes, e.g. encapsulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO93930649A 1992-02-25 1993-02-24 Maalkomponent-maaling NO930649L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US84197692A 1992-02-25 1992-02-25

Publications (2)

Publication Number Publication Date
NO930649D0 true NO930649D0 (no) 1993-02-24
NO930649L NO930649L (no) 1993-08-26

Family

ID=25286232

Family Applications (1)

Application Number Title Priority Date Filing Date
NO93930649A NO930649L (no) 1992-02-25 1993-02-24 Maalkomponent-maaling

Country Status (17)

Country Link
US (1) US5593848A (no)
EP (1) EP0557595B1 (no)
JP (1) JP2925105B2 (no)
CN (1) CN1091521A (no)
AT (1) ATE155889T1 (no)
AU (1) AU662571B2 (no)
BR (1) BR9300639A (no)
CA (1) CA2090282A1 (no)
DE (1) DE69221118T2 (no)
DK (1) DK0557595T3 (no)
ES (1) ES2106121T3 (no)
FI (1) FI930821A (no)
GR (1) GR3024970T3 (no)
MX (1) MX9300965A (no)
NO (1) NO930649L (no)
RU (1) RU2116068C1 (no)
TW (1) TW246716B (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5342790A (en) * 1992-10-30 1994-08-30 Becton Dickinson And Company Apparatus for indirect fluorescent assay of blood samples
AU4101697A (en) * 1996-11-22 1998-05-28 Robert A. Levine Process for enhancing the aggregation and/or agglutination of erythrocytes prior to centrifugation
AU9233698A (en) * 1997-11-22 1999-06-17 Robert A. Levine Method for the detection, identification, enumeration and confirmation of circulating cancer cells and/or hematologic progenitor cells in whole blood
US6197523B1 (en) 1997-11-24 2001-03-06 Robert A. Levine Method for the detection, identification, enumeration and confirmation of circulating cancer and/or hematologic progenitor cells in whole blood
US6911315B2 (en) * 1997-11-24 2005-06-28 David L. Rimm Method for the detection, identification, enumeration and confirmation of virally infected cells and other epitopically defined cells in whole blood
GB0021303D0 (en) * 2000-08-30 2000-10-18 Medinnova Sf Use
WO2004042019A2 (en) * 2002-10-30 2004-05-21 Pointilliste, Inc. Systems for capture and analysis of biological particles and methods using the systems
WO2005016141A1 (en) * 2003-07-09 2005-02-24 California Pacific Medical Center Remote detection of substance delivery to cells
US7996825B2 (en) * 2003-10-31 2011-08-09 Hewlett-Packard Development Company, L.P. Cross-file inlining by using summaries and global worklist
US20060018911A1 (en) * 2004-01-12 2006-01-26 Dana Ault-Riche Design of therapeutics and therapeutics
EP2274611B1 (en) 2008-04-02 2013-06-05 Abbott Point Of Care, Inc. Self-calibrating gradient dilution in a constituent assay and gradient dilution apparatus performed in a thin film sample
EP2281197B1 (en) * 2008-04-09 2015-09-02 Abbott Point Of Care, Inc. Method of detecting very low levels of analyte within a thin film fluid sample contained in a thin thickness chamber
FR2965273B1 (fr) * 2010-09-29 2015-07-17 Centre Nat Rech Scient Procede de preparation d'une structure chimique presentant une partition de phases, apte a generer un spectre de fluorescence specifique et ses applications
US9624474B2 (en) 2010-12-01 2017-04-18 Samsung Electronics Co, Ltd. Method of separating target cell in biological sample
CN102788879B (zh) * 2011-05-20 2015-04-01 常州康卫生物技术有限公司 一种生物检测试剂
ES2881977T3 (es) * 2015-05-06 2021-11-30 Seracare Life Sciences Inc Preparaciones liposomales para cribado no invasivo prenatal o de cáncer

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3862303A (en) * 1972-02-02 1975-01-21 Atomic Energy Commission Method for rapid detection and identification of serological factors
US4027660A (en) * 1976-04-02 1977-06-07 Wardlaw Stephen C Material layer volume determination
US4342739A (en) * 1979-01-09 1982-08-03 Fuji Photo Film Co., Ltd. Novel material for immunological assay of biochemical components and a process for the determination of said components
US4332785A (en) 1980-04-09 1982-06-01 University Patents, Inc. Immunoassay for measurement of reticulocytes, and immunoreactive reagents for use therein
IL64878A (en) * 1982-01-27 1986-01-31 Yissum Res Dev Co Method for detection of and determination of malaria antibodies and malaria antigens in human blood
JPS5984162A (ja) * 1982-11-05 1984-05-15 Toshiba Corp 免疫分析法
JPS6035267A (ja) * 1983-08-05 1985-02-23 Fuji Photo Film Co Ltd 多項目免疫検査法
US5011771A (en) * 1984-04-12 1991-04-30 The General Hospital Corporation Multiepitopic immunometric assay
FR2571498B1 (fr) * 1984-10-04 1988-04-08 Immunotech Sa Procede de separation de cellules utilisant des anticorps et des billes de faible densite
EP0241042A3 (en) * 1986-04-11 1988-05-04 Hitachi, Ltd. A method for cell analysis
US5001225A (en) * 1986-12-08 1991-03-19 Georgetown University Monoclonal antibodies to a pan-malarial antigen
GB2200448B (en) * 1987-01-23 1991-01-16 Univ London Targetted liposomes and their use in immunoassay
US5017472A (en) * 1987-09-09 1991-05-21 Bankert Richard B Microflotation devices used for immunoassays and cell/molecular fractionation
US4978625A (en) * 1987-10-19 1990-12-18 Becton, Dickinson And Company Fluorescence immunoassay using water insoluble dyes
GB2239197B (en) * 1989-12-22 1993-10-06 Syntex Inc Method for separating components in a mixture
JPH03249561A (ja) * 1990-02-28 1991-11-07 Toshiba Corp 免疫分析試薬

Also Published As

Publication number Publication date
BR9300639A (pt) 1993-08-31
GR3024970T3 (en) 1998-01-30
ATE155889T1 (de) 1997-08-15
EP0557595A2 (en) 1993-09-01
TW246716B (no) 1995-05-01
US5593848A (en) 1997-01-14
NO930649L (no) 1993-08-26
EP0557595B1 (en) 1997-07-23
AU662571B2 (en) 1995-09-07
RU2116068C1 (ru) 1998-07-27
DE69221118T2 (de) 1998-02-26
JPH0821833A (ja) 1996-01-23
DE69221118D1 (de) 1997-09-04
EP0557595A3 (no) 1993-11-10
JP2925105B2 (ja) 1999-07-28
MX9300965A (es) 1994-08-31
AU2983692A (en) 1993-08-26
FI930821A (fi) 1993-08-26
FI930821A0 (fi) 1993-02-24
DK0557595T3 (da) 1997-12-29
ES2106121T3 (es) 1997-11-01
CA2090282A1 (en) 1993-08-26
CN1091521A (zh) 1994-08-31

Similar Documents

Publication Publication Date Title
NO930649D0 (no) Maalkomponent-maaling
IL92164A0 (en) Electrochemiluminescent assays
GR910300015T1 (en) Chemiluminescent 1,2-dioxetane compounds
CA2069145A1 (en) Assay method utilizing induced luminescence
ES2151559T3 (es) Aparato y procedimiento de medicion optica.
AU644109B2 (en) Kinetic assay for endotoxin using limulus amebocyte lysate and chromogenic substrate
AU2827389A (en) Electrochemiluminescent rhenium moieties and methods
RU93004564A (ru) Модифицирующая удельный вес маркерная частица, способ анализа пробы биологической жидкости, применение маркерной частицы в анализе пробы биологической жидкости
EP0294105A3 (en) Non-fluorescing, non-reflective polyamide for use in diagnostic testing
DE69626247T2 (de) Disubstituierte 1,2-Dioxetanverbindungen mit erhöhter Wasserlöslichkeit und Zusammensetzungen zum Nachweis
EP0617288A3 (en) Chemiluminescent compounds with long emission wavelength and their use in tests.
CA2425483A1 (en) Assay method utilizing induced luminescence
KR880700270A (ko) 검체의 발광을 이용하여 검체가 존재가능한 매질에서 검체를 검출 및/또는 측정하기 위한 단상 방법
TW223681B (en) Simultaneous determination of multiple analytes using a time-resolved heterogeneous chemilumine-scence assay
ES2090231T3 (es) Elementos analiticos que contienen colorantes bloqueantes no reactivos.
CA2260095A1 (en) Process and device for carrying out quantitative, fluorescence affinity tests
JPS641961A (en) Immunological measurement